Home 2018-08-15T13:46:11+00:00

Theraworx Protect Product Grouping

A Better Way to Fight
Hospital-Acquired Conditions

Now there’s an advanced immunoactive leading the way in immune health — clinically proven, peer-reviewed and published* Theraworx Protect. This broad-spectrum, hygiene and barrier solution reduces hospital-acquired conditions by supporting the skin’s natural defensive functions.

Trusted by leading hospitals as part of their value-based programs, Theraworx Protect was used in the care of more than 2 million ICU patients in 2017, with a projected 4 million more patients in 2018.

Theraworx Protect can be used in a variety of applications, including ICU bathing, pre-surgical bathing, post-operative care, total-body bathing, and more. It can even be applied around mucous membranes and on compromised skin.

Theraworx Protect Clinical Evidence

Proven a safety-superior, non-inferior bathing alternative to 4% CHG in head-to-head, randomized controlled, IRB-approved, independent studies evaluating mucosa and stratum corneum biocompatibility
Proven effective with patented protocols in maintaining the catheter in high-acuity settings
Proven adjunct in the management of incontinence-associated dermatitis
42 clinical studies with extensive peer review acceptance

Theraworx Protect vs. CHG

Find out how Theraworx Protect compares to chlorhexidine gluconate (CHG).

Read More

See How It Works

Theraworx Protect is the first known topical product that supports the skin so it can serve its vital protections.

Theraworx Protect Video Pod Play Button

Theraworx Protect at a Glance

Two-time Innovative Technology Award winner

Clinically proven to manage both macro and micro debris

No prescription required

Gamma irradiation and USP 62 testing on every product batch

Helps preserve the integrity of CHG for its indicated use

Enables implementation of antiseptic stewardship initiatives

Seamless, cost-effective product transition

Easy-to-use impregnated towels

Convenience of total-body bathing with just one product

Manufactured by the 2017 13th fastest growing privately owned company in healthcare, Avadim

Ready to Improve Patient Outcomes?

Make Theraworx Protect a part of your bundle approach to care today.

Get Started

Stay in the Know

For clinical trial results, general information about Theraworx Protect, product news, and more, sign up here.

* Peer-reviewed publications: Journal of Patient Care, Journal of Clinical and Medical Investigations, Annals of Infectious Disease and Epidemiology, American Journal of Infection Control, Journal of Nursing Management, Journal of Emergency Nursing, Infection Control Today, Journal of Internal Medicine Review. For more information regarding Theraworx Protect peer-reviewed articles, IRB-approved research, peer-reviewed and accepted clinical posters, and institutional summaries, call 1-877-677-2723, or email [email protected].
† Data available upon medical inquiry.